Skip to main content

Table 1 Crude reporting odds ratio (cROR) for hepatotoxicity, renal failure, and thrombocytopenia

From: Drug-drug interaction assessment based on a large-scale spontaneous reporting system for hepato- and renal-toxicity, and thrombocytopenia with concomitant low-dose methotrexate and analgesics use

 

Hepatotoxicity

Renal Failure 1

Renal Failure 2

Thrombocytopenia

Drug

cROR (95%CI)

Χ2

cROR (95%CI)

Χ2

cROR (95%CI)

Χ2

cROR (95%CI)

Χ2

Methotrexate

3.1 (3.01–3.2)

5604.43

1.08 (1.02–1.15)

7.88

1.06 (1–1.11)

4.14

2.37 (2.18–2.56)

474.73

Acetaminophen

1.8 (1.71–1.9)

504.44

1.68 (1.54–1.84)

135.29

1.71 (1.58–1.85)

176.31

1.74 (1.52–1.99)

66.98

Loxoprofen

4.78 (4.2–5.45)

669.61

2.89 (2.23–3.73)

71.02

2.52 (1.96–3.23)

56.13

7.89 (6.16–10.1)

379.3

Diclofenac

2.47 (2.29–2.66)

621.61

2.1 (1.85–2.39)

133.89

2.03 (1.8–2.28)

141.9

2.25 (1.85–2.72)

72.54

Ketoprofen

3.56 (3–4.22)

243.97

2.73 (2.01–3.72)

44.61

2.12 (1.55–2.91)

22.95

3.71 (2.47–5.57)

46.33

Celecoxib

1.75 (1.62–1.88)

231.34

1.6 (1.41–1.81)

55.06

1.39 (1.23–1.57)

28.81

1.9 (1.59–2.26)

51.26

Acetylsalicylic Acid

1.67 (1.56–1.79)

226.96

1.77 (1.59–1.98)

109.51

1.91 (1.74–2.1)

181.67

1.87 (1.58–2.2)

57.89

Indometacin

2.73 (2.26–3.29)

119.37

3.46 (2.64–4.55)

90.55

3.04 (2.34–3.96)

76.05

4.56 (3.17–6.55)

80.67

Sulindac

3.43 (2.71–4.35)

118.17

1.82 (1.09–3.04)

5.45

2 (1.28–3.12)

9.69

3.19 (1.76–5.8)

16.28

Ibuprofen

1.62 (1.47–1.78)

98.41

1.39 (1.17–1.64)

14.14

1.42 (1.22–1.65)

20.24

2.07 (1.67–2.58)

45.21

Etodolac

2.39 (1.98–2.89)

87.92

1.81 (1.28–2.57)

11.39

1.86 (1.36–2.55)

15.46

1.07 (0.53–2.14)

0.04

Tiaprofenic Acid

8.01 (4.01–15.99)

49.3

1.92 (0.26–13.88)

0.43

1.57 (0.22–11.34)

0.2

4.6 (0.63–33.3)

2.76

Naproxen

1.41 (1.28–1.55)

47.49

1.31 (1.11–1.55)

9.86

1.31 (1.12–1.52)

11.94

1.69 (1.35–2.13)

20.7

Zaltoprofen

5.47 (3.04–9.85)

40.72

8 (3.7–17.3)

39.51

1.76 (0.43–7.15)

0.64

7.84 (2.48–24.81)

17.3

Rofecoxib

1.63 (1.38–1.92)

34.57

3.82 (3.18–4.59)

237.2

4.61 (3.95–5.38)

456.32

2.11 (1.46–3.05)

16.61

Meloxicam

1.36 (1.22–1.51)

29.82

1.21 (1–1.47)

3.88

1.21 (1.01–1.44)

4.47

1.27 (0.95–1.7)

2.63

Aceclofenac

3.04 (1.9–4.87)

23.85

1.74 (0.65–4.69)

1.24

2.53 (1.19–5.37)

6.25

5.26 (2.16–12.77)

16.81

Lornoxicam

3.26 (1.92–5.55)

21.4

2.37 (0.88–6.39)

3.08

2.43 (1–5.93)

4.09

5.68 (2.11–15.34)

15.04

Mefenamic Acid

2.87 (1.77–4.65)

20.15

1.74 (0.65–4.69)

1.24

1.79 (0.74–4.34)

1.7

5.26 (2.16–12.77)

16.81

Piroxicam

1.94 (1.43–2.64)

18.99

1.61 (0.93–2.79)

2.94

2.04 (1.31–3.19)

10.34

1.77 (0.79–3.95)

1.97

Oxaprozin

2.42 (1.59–3.7)

17.86

0.58 (0.14–2.31)

0.62

1.43 (0.64–3.2)

0.76

0.69 (0.1–4.9)

0.14

Flurbiprofen

2.31 (1.46–3.63)

13.8

1.92 (0.86–4.32)

2.61

2.93 (1.61–5.36)

13.49

6.21 (3.07–12.54)

33.92

  1. Rheumatoid arthritis (RA) cases where methotrexate (MTX) or analgesics were used